Hypersensitivity reactions during treatment with infliximab, etanercept, and adalimumab

Annals of Allergy, Asthma & Immunology

Volume 108, Issue 2, February 2012, Pages 123-124

C. Scheinecker et al.
Cytokines as therapeutic targets: advances and limitations
Immunity
(2008)
R. Maini et al.
Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trialATTRACT Study Group
Lancet
(1999)
J.A. Gomez-Puerta et al.
Etanercept is effective in patients with rheumatoid arthritis with no response to infliximab therapy
Ann Rheum
(2004)
M.E. Weinblatt et al.
Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial
Arthritis Rheum
(2003)

There are more references available in the full text version of this article.